Patent · US Active

Particles for the treatment of cancer in combination with radiotherapy

US10137149B2 · kind B2 · utility

1Cited by
5References
17Claims
0Family size

Assignee

Inventors

Key dates

Filing dateDec 8, 2010
Grant dateNov 27, 2018
Priority date
Expiry dateDec 8, 2030

Classification

  • Technology area (CPC B)Performing Operations; Transporting
  • CPC primaryB82Y5/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The invention provides a particle comprising a metal oxide which is doped with at least one rare earth element, wherein the metal oxide is selected from titanium dioxide, zinc oxide, cerium oxide and mixtures of two or more thereof. The invention also provides a pharmaceutical composition comprising the particles, and to uses of the particles and composition in the treatment and diagnosis of cancer.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.